Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

Last year DeepMind put forward a compelling a solution to a 50-year-old science problem, demonstrating how its AlphaFold AI could predict the 3D structures of unique proteins, laying the groundwork ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that engineer cell fate ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Google DeepMind and Isomorphic Labs today ...

The AI tool AlphaFold has been improved so that it can now predict the shape of very large and complex protein structures. Linköping University researchers have also succeeded in integrating ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ...

Google DeepMind, Google LLC’s artificial intelligence research unit, today detailed a new version of its AlphaFold neural network for biologists. One of the factors that influence the behavior of a ...